Ipsen SA (I7G MU) stock market data APIs
€156.4121
2.01(1.3%)
as of March 18, 2026
Try our APIs with
free plan!
Ipsen SA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for I7G.MU.
Prev. Close
156.4121
Open
158.4194
High
158.9324
Low
156.076
52 wk Range
89.0432-165.9
Market Cap
7 545 M
Dividends (Yield)
0.0134
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Ipsen SA data using free add-ons & libraries
Get Ipsen SA Fundamental Data
Ipsen SA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ipsen SA News
New
Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR
Ipsen Pharma IPN01203 data to be presented at coveted New Drugs on the Horizon program session, demonstrating early potential of this novel T cell activator to transform care in solid tumors ITGA2 re...
Ipsen - February 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
Ipsen Pharma Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Art...
Why ORIC Pharmaceuticals (ORIC) Is Down 15.1% After Ipsen Pulls Tazverik Over Safety Concerns
In recent days, Oric Pharmaceuticals has come under pressure after Ipsen voluntarily withdrew its EZH2 inhibitor Tazverik from the market due to secondary hematologic malignancy concerns in a confirma...
Ipsen appoints Michelle C. Werner as EVP, President of North America
Ipsen Pharma Michelle C. WernerPhoto of Michelle C. Werner, EVP, President of North America·GlobeNewswire Inc. PARIS, FRANCE, 12 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
